GlassScriptPhysician profile
Nitha Jose
NPI 1205387115
$2,323.28
in general payments reported to CMS, 2019-2025
16 companies · $1,450 in 2025
The $1,450 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $120 · 2023: $401 · 2024: $352 · 2025: $1,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,098 · Travel and Lodging: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,098.14 |
| Travel and Lodging | $104.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $385.83 | 2024-2025 | Aralast, Livtencity |
| Glaxosmithkline, LLC. | $359.75 | 2022-2023 | Bexsero, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $325.41 | 2024-2025 | Ofev, Jascayd |
| Paragonix Technologies, INC. | $297.20 | 2025 | |
| Grifols USA, LLC | $209.39 | 2023-2025 | Prolastin-C Liquid |
| Astellas Pharma US INC | $124.98 | 2025 | Cresemba |
| Actelion Pharmaceuticals US, INC. | $119.42 | 2024-2025 | Uptravi, Opsumit |
| Baxter Healthcare | $111.00 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Abbott Laboratories | $104.85 | 2023 | Freestyle Libre 3 |
| Ani Pharmaceuticals, INC. | $85.45 | 2024-2025 | Purified Cortrophin Gel |
| United Therapeutics Corporation | $68.72 | 2025 | Tyvaso |
| Mallinckrodt Hospital Products INC. | $48.13 | 2024 | Terlivaz, Acthar |
| Sanofi-Aventis U.S. LLC | $25.75 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $24.80 | 2025 | Dupixent |
| Alexion Pharmaceuticals, INC. | $18.40 | 2025 | Ultomiris |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitha Jose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.